VB 119
Alternative Names: Anti-CD19 monoclonal antibody - ACELYRIN; VB-119Latest Information Update: 29 Apr 2024
At a glance
- Originator ValenzaBio
- Developer ACELYRIN
- Class Anti-inflammatories; Monoclonal antibodies; Urologics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Focal segmental glomerulosclerosis